Literature DB >> 26659586

The importance of surgical margins in primary malignancies of the liver.

Kelly Lafaro1, Miral Sadaria Grandhi1, Joseph M Herman2, Timothy M Pawlik1.   

Abstract

Resection is an important treatment modality for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). Anatomic resection is generally preferred for HCC. When anatomic resection is not feasible, prospective data have demonstrated an improved outcome among HCC patients who have a resection with wide versus narrow surgical margins. Similarly, among patients with ICC, R1 resection has been associated with worse outcomes. In addition, margin width may also impact risk of recurrence and survival. As such, provided adequate functional liver remnant remains, anatomic resection with wide margins is recommended for HCC and ICC.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  hepatocellular carcinoma; intrahepatic cholangiocarcinoma; liver cancer; surgical margins

Mesh:

Year:  2015        PMID: 26659586     DOI: 10.1002/jso.24123

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  17 in total

1.  Outcomes After Resection of Hepatocellular Carcinoma: Intersection of Travel Distance and Hospital Volume.

Authors:  Eliza W Beal; Rittal Mehta; Katiuscha Merath; Diamantis I Tsilimigras; J Madison Hyer; Anghela Paredes; Mary E Dillhoff; Jordan Cloyd; Aslam Ejaz; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2019-05-08       Impact factor: 3.452

Review 2.  [Image-guided, minimally invasive surgery and other local therapeutic procedures for primary liver tumors].

Authors:  D L Stippel; R Wahba; C J Bruns; A Bunck; C Baues; T Persigehl
Journal:  Chirurg       Date:  2018-11       Impact factor: 0.955

Review 3.  Surgical options for intrahepatic cholangiocarcinoma.

Authors:  Kui Wang; Han Zhang; Yong Xia; Jian Liu; Feng Shen
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

4.  Treatment and outcomes of recurrent hepatocellular carcinomas.

Authors:  Gaëtan-Romain Joliat; Pierre Allemann; Ismail Labgaa; Nicolas Demartines; Nermin Halkic
Journal:  Langenbecks Arch Surg       Date:  2017-05-11       Impact factor: 3.445

5.  Scalp recurrence of cholangiocarcinoma after curative hepatectomy: A report of two cases.

Authors:  Enver Kunduz; Kursat Rahmi Seri N; Mesut Seker
Journal:  Mol Clin Oncol       Date:  2017-10-23

6.  The Prognostic Value of Varying Definitions of Positive Resection Margin in Patients with Colorectal Cancer Liver Metastases.

Authors:  Jane Wang; Georgios Antonios Margonis; Neda Amini; Nikolaos Andreatos; Chunhui Yuan; Christos Damaskos; Efstathios Antoniou; Nikolaos Garmpis; Stefan Buettner; Carlotta Barbon; Amar Deshwar; Jin He; Richard Burkhart; Timothy M Pawlik; Christopher L Wolfgang; Matthew J Weiss
Journal:  J Gastrointest Surg       Date:  2018-04-09       Impact factor: 3.452

7.  Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy.

Authors:  Christopher Coon; Nicholas Berger; Dan Eastwood; Susan Tsai; Kathleen Christians; Harveshp Mogal; Callisia Clarke; T Clark Gamblin
Journal:  Ann Surg Oncol       Date:  2019-11-01       Impact factor: 5.344

Review 8.  Management of centrally located hepatocellular carcinoma: Update 2016.

Authors:  Wei-Bo Yu; Andrew Rao; Victor Vu; Lily Xu; Jian-Yu Rao; Jian-Xiong Wu
Journal:  World J Hepatol       Date:  2017-05-08

9.  Salvage Liver Transplantation Leads to Poorer Outcome in Hepatocellular Carcinoma Compared with Primary Liver Transplantation.

Authors:  Yuhua Shan; Lifeng Huang; Qiang Xia
Journal:  Sci Rep       Date:  2017-03-15       Impact factor: 4.379

10.  A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma.

Authors:  Mengmeng Wang; Yuzhen Gao; Huijuan Feng; Elisa Warner; Mingrui An; Jian'an Jia; Shipeng Chen; Meng Fang; Jun Ji; Xing Gu; Chunfang Gao
Journal:  Cancer Med       Date:  2018-02-23       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.